Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

NCT02067793 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: NRX-1074 1 mg
DRUG: Placebo
DRUG: NRX-1074 5 mg
DRUG: NRX-1074 10 mg

Sponsor

Naurex, Inc, an affiliate of Allergan plc